One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Otavio T Ranzani, Amanda A B Silva, Igor T Peres, Bianca B P Antunes, Thiago W Gonzaga-da-Silva, Daniel R Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A Bozza
doi: https://doi.org/10.1101/2021.10.16.21265095
Otavio T Ranzani
1Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain
2Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Brazil
Amanda A B Silva
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Igor T Peres
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Bianca B P Antunes
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Thiago W Gonzaga-da-Silva
4Rio de Janeiro Municipal Health Department, Rio de Janeiro, Brazil
Daniel R Soranz
4Rio de Janeiro Municipal Health Department, Rio de Janeiro, Brazil
5Public Health National School, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil
José Cerbino-Neto
4Rio de Janeiro Municipal Health Department, Rio de Janeiro, Brazil
6National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil
Silvio Hamacher
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Fernando A Bozza
6National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil
7D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted October 20, 2021.
One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Otavio T Ranzani, Amanda A B Silva, Igor T Peres, Bianca B P Antunes, Thiago W Gonzaga-da-Silva, Daniel R Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A Bozza
medRxiv 2021.10.16.21265095; doi: https://doi.org/10.1101/2021.10.16.21265095
One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Otavio T Ranzani, Amanda A B Silva, Igor T Peres, Bianca B P Antunes, Thiago W Gonzaga-da-Silva, Daniel R Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A Bozza
medRxiv 2021.10.16.21265095; doi: https://doi.org/10.1101/2021.10.16.21265095
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (662)
- Anesthesia (177)
- Cardiovascular Medicine (2587)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12117)
- Forensic Medicine (10)
- Gastroenterology (751)
- Genetic and Genomic Medicine (4017)
- Geriatric Medicine (378)
- Health Economics (670)
- Health Informatics (2595)
- Health Policy (994)
- Hematology (357)
- HIV/AIDS (829)
- Medical Education (397)
- Medical Ethics (107)
- Nephrology (425)
- Neurology (3786)
- Nursing (207)
- Nutrition (560)
- Oncology (1975)
- Ophthalmology (574)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1095)
- Primary Care Research (442)
- Public and Global Health (6458)
- Radiology and Imaging (1372)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (336)
- Surgery (434)
- Toxicology (51)
- Transplantation (185)
- Urology (165)